133 related articles for article (PubMed ID: 1603435)
1. Eosinophilia-myalgia syndrome not associated with L-tryptophan.
Patmas MA
N J Med; 1992 Apr; 89(4):285-6. PubMed ID: 1603435
[TBL] [Abstract][Full Text] [Related]
2. Eosinophilia-myalgia syndrome not associated with the ingestion of nutritional supplements.
Clauw DJ; Flockhart DA; Mullins W; Katz P; Medsger TA
J Rheumatol; 1994 Dec; 21(12):2385-7. PubMed ID: 7699648
[TBL] [Abstract][Full Text] [Related]
3. Eosinophilia-myalgia syndrome: a recent syndrome serving as an alert to new diseases ahead.
Sidransky H
Mod Pathol; 1994 Sep; 7(7):806-10. PubMed ID: 7824518
[TBL] [Abstract][Full Text] [Related]
4. Reduced severity of eosinophilia-myalgia syndrome associated with the consumption of vitamin-containing supplements before illness.
Hatch DL; Goldman LR
Arch Intern Med; 1993 Oct; 153(20):2368-73. PubMed ID: 8215741
[TBL] [Abstract][Full Text] [Related]
5. [Eosinophilia-myalgia syndrome].
Kotake S; Kashiwazaki S
Nihon Rinsho; 1992 Jul; 50(7):1650-5. PubMed ID: 1404896
[TBL] [Abstract][Full Text] [Related]
6. An eosinophilia-myalgia syndrome related disorder associated with exposure to L-5-hydroxytryptophan.
Michelson D; Page SW; Casey R; Trucksess MW; Love LA; Milstien S; Wilson C; Massaquoi SG; Crofford LJ; Hallett M
J Rheumatol; 1994 Dec; 21(12):2261-5. PubMed ID: 7699627
[TBL] [Abstract][Full Text] [Related]
7. L-tryptophan-induced eosinophilia-myalgia syndrome. I. Report of two cases with pseudoxanthoma-elasticum-like skin changes.
Mainetti C; Schmied E; Masouyé I; Chavaz P; Saurat JH
Dermatologica; 1991; 183(1):57-61. PubMed ID: 1769422
[TBL] [Abstract][Full Text] [Related]
8. A murine model of the eosinophilia-myalgia syndrome induced by 1,1'-ethylidenebis (L-tryptophan).
Silver RM; Ludwicka A; Hampton M; Ohba T; Bingel SA; Smith T; Harley RA; Maize J; Heyes MP
J Clin Invest; 1994 Apr; 93(4):1473-80. PubMed ID: 8163652
[TBL] [Abstract][Full Text] [Related]
9. Eosinophilia-myalgia syndrome among the non-L-tryptophan users and pre-epidemic cases.
Sullivan EA; Staehling N; Philen RM
J Rheumatol; 1996 Oct; 23(10):1784-7. PubMed ID: 8895159
[TBL] [Abstract][Full Text] [Related]
10. [L-tryptophan and the eosinophilia-myalgia syndrome].
Prick JJ
Ned Tijdschr Geneeskd; 1990 Aug; 134(31):1516-7. PubMed ID: 2392173
[No Abstract] [Full Text] [Related]
11. A decomposition product of a contaminant implicated in L-tryptophan eosinophilia myalgia syndrome affects spinal cord neuronal cell death and survival through stereospecific, maturation and partly interleukin-1-dependent mechanisms.
Brenneman DE; Page SW; Schultzberg M; Thomas FS; Zelazowski P; Burnet P; Avidor R; Sternberg EM
J Pharmacol Exp Ther; 1993 Aug; 266(2):1029-35. PubMed ID: 8355179
[TBL] [Abstract][Full Text] [Related]
12. The natural history of eosinophilia-myalgia syndrome in a tryptophan-exposed cohort in South Carolina.
Sullivan EA; Kamb ML; Jones JL; Meyer P; Philen RM; Falk H; Sinks T
Arch Intern Med; 1996 May; 156(9):973-9. PubMed ID: 8624177
[TBL] [Abstract][Full Text] [Related]
13. ["Eosinophilia-myalgia" syndrome due to L-tryptophan containing products. Cooperative evaluation of French Regional Centers of Pharmacovigilance. Analysis of 24 cases].
Castot A; Bidault I; Bournerias I; Carlier P; Efthymiou ML
Therapie; 1991; 46(5):355-65. PubMed ID: 1754978
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for developing eosinophilia myalgia syndrome among L-tryptophan users in New York.
Back EE; Henning KJ; Kallenbach LR; Brix KA; Gunn RA; Melius JM
J Rheumatol; 1993 Apr; 20(4):666-72. PubMed ID: 8496862
[TBL] [Abstract][Full Text] [Related]
15. Epidemiologic studies of the association of L-tryptophan with the eosinophilia-myalgia syndrome: a critique.
Shapiro S
J Rheumatol Suppl; 1996 Oct; 46():44-58; discussion 58-9. PubMed ID: 8895181
[TBL] [Abstract][Full Text] [Related]
16. Review of L-tryptophan and eosinophilia-myalgia syndrome.
Roufs JB
J Am Diet Assoc; 1992 Jul; 92(7):844-50. PubMed ID: 1624654
[TBL] [Abstract][Full Text] [Related]
17. A contaminant of L-tryptophan enhances expression of dermal collagen in a murine model of eosinophilia myalgia syndrome.
Suzuki S; Tourkina E; Ludwicka A; Hampton M; Bolster M; Maize J; Silver R
Proc Assoc Am Physicians; 1996 Jul; 108(4):315-22. PubMed ID: 8863345
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic bias in clinical decision making: an example of L-tryptophan and the diagnosis of eosinophilia-myalgia syndrome.
Wagner KR; Elmore JG; Horwitz RI
J Rheumatol; 1996 Dec; 23(12):2079-85. PubMed ID: 8970044
[TBL] [Abstract][Full Text] [Related]
19. Eosinophilia-myalgia syndrome associated with ingestion of L-tryptophan.
Keating JP; Wardill K; Viggiano J
N Z Med J; 1992 Aug; 105(939):317. PubMed ID: 1386918
[No Abstract] [Full Text] [Related]
20. Structural characterization of contaminants found in commercial preparations of melatonin: similarities to case-related compounds from L-tryptophan associated with eosinophilia-myalgia syndrome.
Williamson BL; Tomlinson AJ; Mishra PK; Gleich GJ; Naylor S
Chem Res Toxicol; 1998 Mar; 11(3):234-40. PubMed ID: 9544622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
